[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide].

Troshina EA, Antsiferov MB, Ametov AS, Galstyan GR, Markova TN, Romantsova TI, Mazurina NV, Koteshkova OM

DOI: 10.14341/probl13677
Published: 2025 Dec 2
Container: Problemy endokrinologii
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.14341/probl13677,
  title = {[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide].},
  author = {Troshina EA and Antsiferov MB and Ametov AS and Galstyan GR and Markova TN and Romantsova TI and Mazurina NV and Koteshkova OM},
  year = {2025},
  journal = {Problemy endokrinologii},
  doi = {10.14341/probl13677},
  url = {https://doi.org/10.14341/probl13677}
}

RIS

TY  - JOUR
TI  - [A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide].
AU  - Troshina EA
AU  - Antsiferov MB
AU  - Ametov AS
AU  - Galstyan GR
AU  - Markova TN
AU  - Romantsova TI
AU  - Mazurina NV
AU  - Koteshkova OM
PY  - 2025
JO  - Problemy endokrinologii
DO  - 10.14341/probl13677
UR  - https://doi.org/10.14341/probl13677
ER  -

APA

EA, T., MB, A., AS, A., GR, G., TN, M., TI, R., NV, M., & OM, K. (2025). [A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide].. Problemy endokrinologii. https://doi.org/10.14341/probl13677

Source records

pubmed · retrieved 2026-09-27T09:46:20.950Z